Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 22

1.

Urogynecological conditions associated with overactive bladder symptoms in women.

Forde JC, Davila JL, Marks BK, Epstein M, Tsui JF, Weiss JP, Blaivas JG.

Can Urol Assoc J. 2017 Mar-Apr;11(3-4):E83-E87. doi: 10.5489/cuaj.3962. Epub 2017 Mar 16.

2.

Identification of Key Odorants in Used Disposable Absorbent Incontinence Products.

Hall G, Alenljung S, Forsgren-Brusk U.

J Wound Ostomy Continence Nurs. 2017 May/Jun;44(3):269-276. doi: 10.1097/WON.0000000000000325.

3.

Positive association of female overactive bladder symptoms and estrogen deprivation: A nationwide population-based cohort study in Taiwan.

Cheng CL, Li JR, Lin CH, de Groat WC.

Medicine (Baltimore). 2016 Jul;95(28):e4107. doi: 10.1097/MD.0000000000004107.

4.

Persistence and compliance with medication management in the treatment of overactive bladder.

Kim TH, Lee KS.

Investig Clin Urol. 2016 Mar;57(2):84-93. doi: 10.4111/icu.2016.57.2.84. Epub 2016 Mar 11. Review.

5.

Postmenopausal overactive bladder.

Tomaszewski J.

Prz Menopauzalny. 2014 Dec;13(6):313-29. doi: 10.5114/pm.2014.47984. Epub 2014 Dec 30.

6.
7.

α1-adrenergic receptor antagonists versus placebo for female lower urinary tract symptoms: A meta-analysis.

Zhang P, Hu WL, Cheng B, Cheng L, Xiong XK.

Exp Ther Med. 2015 Jul;10(1):251-256. Epub 2015 Apr 23.

8.

Pathogens in Urine from a Female Patient with Overactive Bladder Syndrome Detected by Culture-independent High Throughput Sequencing: A Case Report.

Siddiqui H, Lagesen K, Nederbragt AJ, Eri LM, Jeansson SL, Jakobsen KS.

Open Microbiol J. 2014 Dec 31;8:148-53. doi: 10.2174/1874285801408010148. eCollection 2014.

9.

Does fesoterodine have a role in the treatment of poorly managed patients with overactive bladder?

Morris V, Wagg A.

Drug Des Devel Ther. 2014 Jan 9;8:113-9. doi: 10.2147/DDDT.S40032. eCollection 2014. Review.

10.

Clinical utility of transdermal delivery of oxybutynin gel via a metered-dose pump in the management of overactive bladder.

Wagg A.

Res Rep Urol. 2012 Nov 27;4:57-64. doi: 10.2147/RRU.S28943. eCollection 2012. Review.

11.

Prevalence and risk factors of urinary incontinence among Estonian postmenopausal women.

Kirss F, Lang K, Toompere K, Veerus P.

Springerplus. 2013 Oct 17;2:524. doi: 10.1186/2193-1801-2-524. eCollection 2013.

12.

Increased serum adipokines implicate chronic inflammation in the pathogenesis of overactive bladder syndrome refractory to antimuscarinic therapy.

Liu HT, Jiang YH, Kuo HC.

PLoS One. 2013 Oct 1;8(10):e76706. doi: 10.1371/journal.pone.0076706. eCollection 2013.

13.

Impact of vulvovaginal health on postmenopausal women: a review of surveys on symptoms of vulvovaginal atrophy.

Parish SJ, Nappi RE, Krychman ML, Kellogg-Spadt S, Simon JA, Goldstein JA, Kingsberg SA.

Int J Womens Health. 2013 Jul 29;5:437-47. doi: 10.2147/IJWH.S44579. Print 2013.

14.

Incidence of lower urinary tract symptoms in a population-based study of men and women.

Maserejian NN, Chen S, Chiu GR, Wager CG, Kupelian V, Araujo AB, McKinlay JB.

Urology. 2013 Sep;82(3):560-4. doi: 10.1016/j.urology.2013.05.009. Epub 2013 Jul 19.

15.

Intake of caffeinated, carbonated, or citrus beverage types and development of lower urinary tract symptoms in men and women.

Maserejian NN, Wager CG, Giovannucci EL, Curto TM, McVary KT, McKinlay JB.

Am J Epidemiol. 2013 Jun 15;177(12):1399-410. doi: 10.1093/aje/kws411. Epub 2013 May 30.

16.

Prevalence, incidence and remission of urinary incontinence in women: longitudinal data from the Norwegian HUNT study (EPINCONT).

Ebbesen MH, Hunskaar S, Rortveit G, Hannestad YS.

BMC Urol. 2013 May 30;13:27. doi: 10.1186/1471-2490-13-27.

17.

Overactive bladder, differential diagnosis, and clinical utility of fesoterodine.

Wyndaele JJ.

Int J Gen Med. 2012;5:943-51. doi: 10.2147/IJGM.S24236. Epub 2012 Nov 12.

18.

Urgency urinary incontinence in women 50 years or older: incidence, remission, and predictors of change.

Komesu YM, Schrader RM, Rogers RG, Ketai LH.

Female Pelvic Med Reconstr Surg. 2011 Jan;17(1):17-23. doi: 10.1097/SPV.0b013e31820446e6.

19.

Intakes of vitamins and minerals in relation to urinary incontinence, voiding, and storage symptoms in women: a cross-sectional analysis from the Boston Area Community Health survey.

Maserejian NN, Giovannucci EL, McVary KT, McKinlay JB.

Eur Urol. 2011 Jun;59(6):1039-47. doi: 10.1016/j.eururo.2011.03.008. Epub 2011 Mar 15.

20.

Genetic influences are important for most but not all lower urinary tract symptoms: a population-based survey in a cohort of adult Swedish twins.

Wennberg AL, Altman D, Lundholm C, Klint A, Iliadou A, Peeker R, Fall M, Pedersen NL, Milsom I.

Eur Urol. 2011 Jun;59(6):1032-8. doi: 10.1016/j.eururo.2011.03.007. Epub 2011 Mar 21.

Supplemental Content

Support Center